An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia

• Status: Completed
• Trial end date: 2003-08-01

Summary

To validate the efficacy and safety of azithromycin for the treatment of Chinese patients hospitalized with community-acquired pneumonia (CAP), compared with cefuroxime or the combination of cefuroxime plus oral erythromycin.

• Phase: Phase 3

Details

• Lead Sponsor: Pfizer
• Treatments: Azithromycin; Cefuroxime; Cefuroxime axetil; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Erythromycin stearate